Infographic: Gene Activity in the Cellular Afterlife

Low oxygen resuscitates gene transcription after death.

Written byIris Kulbatski, PhD
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

After an organism dies, most of its cells begin to extinguish activity and die shortly afterward. However, other cells exhibit a curious behavior. Instead of winding down their operations, certain gene activities resurrect.1

Image of cells dividing and a human embryo

Low Oxygen Beginnings

During the earliest stages of embryonic development, stem cells proliferate in a low oxygen environment. The genes that drive this stage are active for a short period of time. After the blastocyst implants into the uterus, eventually, oxygen levels increase and gene activity that was previously maintained by low oxygen levels silences.2,3

Survival Instinct

Cellular life after death may seem paradoxical, but sudden changes in oxygen levels trigger protective responses in cells. Genes that are transcribed during the low oxygen phase of embryonic development are reactivated when oxygen levels plumet after organismal death. Many emergency-mode genes also activate to support cell survival, including those involved in inflammation, immunity, stress responses, and cancer. Scientists studied this in zebrafish and mice, as well as human blood, prostate, liver, and brain tissue samples.1,4,5,6,7

Illustration of a human combined with DNA and a hand holding DNA strands
Illustration of a magnifying glass over a human chest

Real-world Zombie Genes

There are practical applications for understanding why and how genes are activated after death. For example, forensic scientists apply insights from postmortem gene transcription to estimate the time of death in criminal cases. Scientists also use information about cancer gene reactivation to improve organ transplant outcomes. Performing transplant surgery before these genes become active may help reduce the high incidence of cancer in organ transplant recipients.8

MODIFIED FROM © ISTOCK.COM, Ilya Lukichev, LuckyStep48; DESIGNED BY ERIN LEMIEUX

Read the full story.

Related Topics

Meet the Author

  • Iris Kulbatski, PhD

    Iris, a neuroscientist by training and word surgeon by trade, is an associate science editor with The Scientist's Creative Services Team. Her work has appeared in various online and print publications, including Discover Magazine, Medgadget, National Post, The Toronto Star and others. She holds a PhD in Medical Science and a Certificate in Creative Writing from the University of Toronto. Her left and right brain converse on a regular basis. Once in a while, they collaborate.

    View Full Profile

Published In

December 2023 issue cover
Winter 2023

Ephemeral Life

Recent advances in modeling the human placenta may inform placental disorders like preeclampsia

Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies